|
1
|
Liebig C, Ayala G, Wilks JA, Berger DH and
Albo D: Perineural invasion in cancer: A review of the literature.
Cancer. 115:3379–3391. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alderton GK: Microenvironment: An exercise
in restraint. Nat Rev Cancer. 14:4492014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bapat AA, Hostetter G, Von Hoff DD and Han
H: Perineural invasion and associated pain in pancreatic cancer.
Nat Rev Cancer. 11:695–707. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yi SQ, Miwa K, Ohta T, Kayahara M,
Kitagawa H, Tanaka A, Shimokawa T, Akita K and Tanaka S:
Innervation of the pancreas from the perspective of perineural
invasion of pancreatic cancer. Pancreas. 27:225–229. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng P, Jin G, Hu X, Shi M, Zhang Y, Liu
R, Zhou Y, Shao C, Zheng J and Zhu M: Analysis of tumor-induced
lymphangiogenesis and lymphatic vessel invasion of pancreatic
carcinoma in the peripheral nerve plexus. Cancer Sci.
103:1756–1763. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Makino I, Kitagawa H, Ohta T, Nakagawara
H, Tajima H, Ohnishi I, Takamura H, Tani T and Kayahara M: Nerve
plexus invasion in pancreatic cancer: Spread patterns on
histopathologic and embryological analyses. Pancreas. 37:358–365.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chari ST, Leibson CL, Rabe KG, Timmons LJ,
Ransom J, de Andrade M and Petersen GM: Pancreatic
cancer-associated diabetes mellitus: Prevalence and temporal
association with diagnosis of cancer. Gastroenterology. 134:95–101.
2008. View Article : Google Scholar
|
|
8
|
Satija A, Spiegelman D, Giovannucci E and
Hu FB: Type 2 diabetes and risk of cancer. BMJ. 350:g77072015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liao WC, Tu YK, Wu MS, Lin JT, Wang HP and
Chien KL: Blood glucose concentration and risk of pancreatic
cancer: Systematic review and dose-response meta-analysis. BMJ.
349:g73712015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pannala R, Basu A, Petersen GM and Chari
ST: New-onset diabetes: A potential clue to the early diagnosis of
pancreatic cancer. Lancet Oncol. 10:88–95. 2009. View Article : Google Scholar :
|
|
11
|
Giovannucci E and Michaud D: The role of
obesity and related metabolic disturbances in cancers of the colon,
prostate, and pancreas. Gastroenterology. 132:2208–2225. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li J and Ma Q: Hyperglycemia promotes the
perineural invasion in pancreatic cancer. Med Hypotheses.
71:386–389. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He S, Chen CH, Chernichenko N, He S, Bakst
RL, Barajas F, Deborde S, Allen PJ, Vakiani E, Yu Z, et al: GFRα1
released by nerves enhances cancer cell perineural invasion through
GDNF-RET signaling. Proc Natl Acad Sci USA. 111:E2008–E2017. 2014.
View Article : Google Scholar
|
|
14
|
Gao L, Bo H, Wang Y, Zhang J and Zhu M:
Neurotrophic factor artemin promotes invasiveness and neurotrophic
function of pancreatic adenocarcinoma in vivo and in vitro.
Pancreas. 44:134–143. 2015. View Article : Google Scholar
|
|
15
|
Martínez-Bosch N, Fernández-Barrena MG,
Moreno M, Ortiz-Zapater E, Munné-Collado J, Iglesias M, André S,
Gabius HJ, Hwang RF, Poirier F, et al: Galectin-1 drives pancreatic
carcinogenesis through stroma remodeling and Hedgehog signaling
activation. Cancer Res. 74:3512–3524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li X, Wang Z, Ma Q, Xu Q, Liu H, Duan W,
Lei J, Ma J, Wang X, Lv S, et al: Sonic hedgehog paracrine
signaling activates stromal cells to promote perineural invasion in
pancreatic cancer. Clin Cancer Res. 20:4326–4338. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Yang H, Abel EV, Ney GM, Palmbos
PL, Bednar F, Zhang Y, Leflein J, Waghray M, Owens S, et al: ATDC
induces an invasive switch in KRAS-induced pancreatic
tumorigenesis. Genes Dev. 29:171–183. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sherman MH, Yu RT, Engle DD, Ding N,
Atkins AR, Tiriac H, Collisson EA, Connor F, Van Dyke T, Kozlov S,
et al: Vitamin D receptor-mediated stromal reprogramming suppresses
pancreatitis and enhances pancreatic cancer therapy. Cell.
159:80–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Witz IP and Levy-Nissenbaum O: The tumor
microenvironment in the post-PAGET era. Cancer Lett. 242:1–10.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Helm O, Mennrich R, Petrick D, Goebel L,
Freitag-Wolf S, Röder C, Kalthoff H, Röcken C, Sipos B, Kabelitz D,
et al: Comparative characterization of stroma cells and ductal
epithelium in chronic pancreatitis and pancreatic ductal
adenocarcinoma. PLoS One. 9:e943572014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gore J and Korc M: Pancreatic cancer
stroma: Friend or foe? Cancer Cell. 25:711–712. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Heinemann V, Reni M, Ychou M, Richel DJ,
Macarulla T and Ducreux M: Tumour-stroma interactions in pancreatic
ductal adenocarcinoma: Rationale and current evidence for new
therapeutic strategies. Cancer Treat Rev. 40:118–128. 2014.
View Article : Google Scholar
|
|
24
|
Rhim AD, Oberstein PE, Thomas DH, Mirek
ET, Palermo CF, Sastra SA, Dekleva EN, Saunders T, Becerra CP,
Tattersall IW, et al: Stromal elements act to restrain, rather than
support, pancreatic ductal adenocarcinoma. Cancer Cell. 25:735–747.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Özdemir BC, Pentcheva-Hoang T, Carstens
JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C,
Novitskiy SV, et al: Depletion of carcinoma-associated fibroblasts
and fibrosis induces immunosuppression and accelerates pancreas
cancer with reduced survival. Cancer Cell. 25:719–734. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karademir S, Sökmen S, Terzi C, Sağol O,
Özer E, Astarcioğlu H, Coker A and Astarcioğlu I: Tumor
angiogenesis as a prognostic predictor in pancreatic cancer. J
Hepatobiliary Pancreat Surg. 7:489–495. 2000. View Article : Google Scholar
|
|
27
|
Khorana AA, Ahrendt SA, Ryan CK, Francis
CW, Hruban RH, Hu YC, Hostetter G, Harvey J and Taubman MB: Tissue
factor expression, angiogenesis, and thrombosis in pancreatic
cancer. Clin Cancer Res. 13:2870–2875. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wente MN, Keane MP, Burdick MD, Friess H,
Büchler MW, Ceyhan GO, Reber HA, Strieter RM and Hines OJ: Blockade
of the chemokine receptor CXCR2 inhibits pancreatic cancer
cell-induced angiogenesis. Cancer Lett. 241:221–227. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wong PP, Demircioglu F, Ghazaly E,
Alrawashdeh W, Stratford MR, Scudamore CL, Cereser B,
Crnogorac-Jurcevic T, McDonald S, Elia G, et al: Dual-action
combination therapy enhances angiogenesis while reducing tumor
growth and spread. Cancer Cell. 27:123–137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Clark CE, Hingorani SR, Mick R, Combs C,
Tuveson DA and Vonderheide RH: Dynamics of the immune reaction to
pancreatic cancer from inception to invasion. Cancer Res.
67:9518–9527. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bayne LJ, Beatty GL, Jhala N, Clark CE,
Rhim AD, Stanger BZ and Vonderheide RH: Tumor-derived
granulocyte-macrophage colony-stimulating factor regulates myeloid
inflammation and T cell immunity in pancreatic cancer. Cancer Cell.
21:822–835. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Greten TF: Myeloid-derived suppressor
cells in pancreatic cancer: more than a hidden barrier for
antitumour immunity? Gut. 63:1690–1691. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Neesse A, Michl P, Frese KK, Feig C, Cook
N, Jacobetz MA, Lolkema MP, Buchholz M, Olive KP, Gress TM, et al:
Stromal biology and therapy in pancreatic cancer. Gut. 60:861–868.
2011. View Article : Google Scholar
|
|
34
|
Schlomann U, Koller G, Conrad C, Ferdous
T, Golfi P, Garcia AM, Höfling S, Parsons M, Costa P, Soper R, et
al: ADAM8 as a drug target in pancreatic cancer. Nat Commun.
6:61752015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kahlert C, Fiala M, Musso G, Halama N,
Keim S, Mazzone M, Lasitschka F, Pecqueux M, Klupp F, Schmidt T, et
al: Prognostic impact of a compartment-specific angiogenic marker
profile in patients with pancreatic cancer. Oncotarget.
5:12978–12989. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jacobs EJ, Newton CC, Silverman DT,
Nogueira LM, Albanes D, Männistö S, Pollak M and
Stolzenberg-Solomon RZ: Serum transforming growth factor-β1 and
risk of pancreatic cancer in three prospective cohort studies.
Cancer Causes Control. 25:1083–1091. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hermann PC, Huber SL, Herrler T, Aicher A,
Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations
of cancer stem cells determine tumor growth and metastatic activity
in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007.
View Article : Google Scholar
|
|
38
|
Bai X, Zhi X, Zhang Q, Liang F, Chen W,
Liang C, Hu Q, Sun X, Zhuang Z and Liang T: Inhibition of protein
phosphatase 2A sensitizes pancreatic cancer to chemotherapy by
increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis.
Cancer Lett. 355:281–287. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Farrow B, Albo D and Berger DH: The role
of the tumor microenvironment in the progression of pancreatic
cancer. J Surg Res. 149:319–328. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ryan DP, Hong TS and Bardeesy N:
Pancreatic adenocarcinoma. N Engl J Med. 371:1039–1049. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bockhorn M, Uzunoglu FG, Adham M, Imrie C,
Milicevic M, Sandberg AA, Asbun HJ, Bassi C, Büchler M, Charnley
RM, et al; International Study Group of Pancreatic Surgery.
Borderline resectable pancreatic cancer: A consensus statement by
the International Study Group of Pancreatic Surgery (ISGPS).
Surgery. 155:977–988. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fouquet T, Germain A, Brunaud L, Bresler L
and Ayav A: Is perineural invasion more accurate than other factors
to predict early recurrence after pancreatoduodenectomy for
pancreatic head adenocarcinoma? World J Surg. 38:2132–2137. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kimura W and Makuuchi M: Suihi geka no
youten to mouten. Bunkodo; Tokyo: 2009, (In Japanese).
|
|
44
|
Wagner M, Redaelli C, Lietz M, Seiler CA,
Friess H and Büchler MW: Curative resection is the single most
important factor determining outcome in patients with pancreatic
adenocarcinoma. Br J Surg. 91:586–594. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Weitz J, Rahbari N, Koch M and Büchler MW:
The ‘artery first’ approach for resection of pancreatic head
cancer. J Am Coll Surg. 210:e1–e4. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Verbeke CS, Leitch D, Menon KV, McMahon
MJ, Guillou PJ and Anthoney A: Redefining the R1 resection in
pancreatic cancer. Br J Surg. 93:1232–1237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Esposito I, Kleeff J, Bergmann F, Reiser
C, Herpel E, Friess H, Schirmacher P and Büchler MW: Most
pancreatic cancer resections are R1 resections. Ann Surg Oncol.
15:1651–1660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cameron JL, Riall TS, Coleman J and
Belcher KA: One thousand consecutive pancreaticoduodenectomies. Ann
Surg. 244:10–15. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Schmidt CM, Powell ES, Yiannoutsos CT,
Howard TJ, Wiebke EA, Wiesenauer CA, Baumgardner JA, Cummings OW,
Jacobson LE, Broadie TA, et al: Pancreaticoduodenectomy: A 20-year
experience in 516 patients. Arch Surg. 139:718–725; discussion
725–727. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Verbeke CS: Resection margins and R1 rates
in pancreatic cancer - are we there yet? Histopathology.
52:787–796. 2008. View Article : Google Scholar
|
|
51
|
Gaedcke J, Gunawan B, Grade M, Szöke R,
Liersch T, Becker H and Ghadimi BM: The mesopancreas is the primary
site for R1 resection in pancreatic head cancer: Relevance for
clinical trials. Langenbecks Arch Surg. 395:451–458. 2010.
View Article : Google Scholar :
|
|
52
|
Agrawal MK, Thakur DS, Somashekar U,
Chandrakar SK and Sharma D: Mesopancreas: Myth or reality? JOP.
11:230–233. 2010.PubMed/NCBI
|
|
53
|
Adham M and Singhirunnusorn J: Surgical
technique and results of total mesopancreas excision (TMpE) in
pancreatic tumors. Eur J Surg Oncol. 38:340–345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Gockel I, Domeyer M, Wolloscheck T,
Konerding MA and Junginger T: Resection of the mesopancreas (RMP):
A new surgical classification of a known anatomical space. World J
Surg Oncol. 5:442007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Bouassida M, Mighri MM, Chtourou MF and
Sassi S, Touinsi H, Hajji H and Sassi S: Retroportal lamina or
mesopancreas? Lessons learned by anatomical and histological study
of thirty three cadaveric dissections. Int J Surg. 11:834–836.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Dumitrascu T and Popescu I: Total
mesopancreas excision in pancreatic head adenocarcinoma: The same
impact as total mesorectal excision in rectal carcinoma? Comment on
article “surgical technique and results of total mesopancreas
excision in pancreatic tumours” by Adham M and Singhirunnusorn J,
Eur J Surg Oncol, 2012. Eur J Surg Oncol. 38:725author reply 726.
2012. View Article : Google Scholar
|
|
57
|
Chowdappa R and Challa VR: Mesopancreas in
pancreatic cancer: where do we stand - review of literature. Indian
J Surg Oncol. 6:69–74. 2014. View Article : Google Scholar
|
|
58
|
Kawabata Y, Tanaka T, Nishi T, Monma H,
Yano S and Tajima Y: Appraisal of a total meso-pancreatoduodenum
excision with pancreaticoduodenectomy for pancreatic head
carcinoma. Eur J Surg Oncol. 38:574–579. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Jang JY, Kang MJ, Heo JS, Choi SH, Choi
DW, Park SJ, Han SS, Yoon DS, Yu HC, Kang KJ, et al: A prospective
randomized controlled study comparing outcomes of standard
resection and extended resection, including dissection of the nerve
plexus and various lymph nodes, in patients with pancreatic head
cancer. Ann Surg. 259:656–664. 2014. View Article : Google Scholar
|
|
60
|
Nimura Y, Nagino M, Takao S, Takada T,
Miyazaki K, Kawarada Y, Miyagawa S, Yamaguchi A, Ishiyama S, Takeda
Y, et al: Standard versus extended lymphadenectomy in radical
pancreatoduodenectomy for ductal adenocarcinoma of the head of the
pancreas: Long-term results of a Japanese multicenter randomized
controlled trial. J Hepatobiliary Pancreat Sci. 19:230–241. 2012.
View Article : Google Scholar
|
|
61
|
Michalski CW, Kleeff J, Wente MN, Diener
MK, Büchler MW and Friess H: Systematic review and meta-analysis of
standard and extended lymphadenectomy in pancreaticoduodenectomy
for pancreatic cancer. Br J Surg. 94:265–273. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Farnell MB, Pearson RK, Sarr MG, DiMagno
EP, Burgart LJ, Dahl TR, Foster N and Sargent DJ; Pancreas Cancer
Working Group. A prospective randomized trial comparing standard
pancreatoduodenectomy with pancreatoduodenectomy with extended
lymphadenectomy in resectable pancreatic head adenocarcinoma.
Surgery. 138:618–628; discussion 628–630. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lee A, Chiu CH, Cho MWA, Gomersall CD, Lee
KF, Cheung YS and Lai PB: Factors associated with failure of
enhanced recovery protocol in patients undergoing major
hepatobiliary and pancreatic surgery: A retrospective cohort study.
BMJ Open. 4:e0053302014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Pfister DG: The just price of cancer drugs
and the growing cost of cancer care: Oncologists need to be part of
the solution. J Clin Oncol. 31:3487–3489. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Short MN, Aloia TA and Ho V: The influence
of complications on the costs of complex cancer surgery. Cancer.
120:1035–1041. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Sanford DE, Sanford AM, Fields RC, Hawkins
WG, Strasberg SM and Linehan DC: Severe nutritional risk predicts
decreased long-term survival in geriatric patients undergoing
pancreaticoduodenectomy for benign disease. J Am Coll Surg.
219:1149–1156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Deisseroth K, Feng G, Majewska AK,
Miesenböck G, Ting A and Schnitzer MJ: Next-generation optical
technologies for illuminating genetically targeted brain circuits.
J Neurosci. 26:10380–10386. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Fenno L, Yizhar O and Deisseroth K: The
development and application of optogenetics. Annu Rev Neurosci.
34:389–412. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Nagel G, Brauner M, Liewald JF, Adeishvili
N, Bamberg E and Gottschalk A: Light activation of
channelrhodopsin-2 in excitable cells of Caenorhabditis elegans
triggers rapid behavioral responses. Curr Biol. 15:2279–2284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Li X, Gutierrez DV, Hanson MG, Han J, Mark
MD, Chiel H, Hegemann P, Landmesser LT and Herlitze S: Fast
noninvasive activation and inhibition of neural and network
activity by vertebrate rhodopsin and green algae channelrhodopsin.
Proc Natl Acad Sci USA. 102:17816–17821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhang F, Wang LP, Boyden ES and Deisseroth
K: Channelrhodopsin-2 and optical control of excitable cells. Nat
Methods. 3:785–792. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Cardin JA, Carlén M, Meletis K, Knoblich
U, Zhang F, Deisseroth K, Tsai LH and Moore CI: Targeted
optogenetic stimulation and recording of neurons in vivo using
cell-type-specific expression of Channelrhodopsin-2. Nat Protoc.
5:247–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Han X, Qian X, Bernstein JG, Zhou HH,
Franzesi GT, Stern P, Bronson RT, Graybiel AM, Desimone R and
Boyden ES: Millisecond-timescale optical control of neural dynamics
in the nonhuman primate brain. Neuron. 62:191–198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Yizhar O, Fenno LE, Davidson TJ, Mogri M
and Deisseroth K: Optogenetics in neural systems. Neuron. 71:9–34.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Adamantidis AR, Zhang F, Aravanis AM,
Deisseroth K and de Lecea L: Neural substrates of awakening probed
with optogenetic control of hypocretin neurons. Nature.
450:420–424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Hung J and Colicos MA: Astrocytic
Ca2+ waves guide CNS growth cones to remote regions of
neuronal activity. PLoS One. 3:e36922008. View Article : Google Scholar
|
|
79
|
Adelsberger H, Grienberger C, Stroh A and
Konnerth A: In vivo calcium recordings and channelrhodopsin-2
activation through an optical fiber. Cold Spring Harbor Protocols.
2014:pdb. prot084145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhang Y, Yue J, Ai M, Ji Z, Liu Z, Cao X
and Li L: Channelrhodopsin-2-expressed dorsal root ganglion neurons
activates calcium channel currents and increases action potential
in spinal cord. Spine. 39:E865–E869. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Fenno LE and Deisseroth K: Optogenetic
tools for control of neural activity. Optical Imaging of
Neocortical Dynamics. Springer; pp. 73–86. 2014, View Article : Google Scholar
|
